Kerecis Expands Silicone Fish-Skin Combination Product Range with Shield Spiral, Offering Advanced Customizable Wound Care Solutions
2024年7月6日 - 1:03AM
ビジネスワイヤ(英語)
Product offers added benefit of flexible graft tailoring to fit
various wound sizes
Kerecis, the company pioneering the use of sustainably sourced
fish skin and fatty acids in cellular therapy and tissue
regeneration and protection, today announced the availability of
Shield Spiral, an extension of the Kerecis Shield silicone
fish-skin combination product range.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240705610282/en/
Kerecis Expands Silicone Fish-Skin
Combination Product Range with Shield Spiral, Offering Advanced
Customizable Wound Care Solutions (Photo: Business Wire)
The patented, intact fish-skin graft and silicone combination,
features perforated fenestration marks cut in a unique spiral
pattern, allowing easy customization. The 30 mm graft can be
reduced to as small as 15 mm by peeling away the 2 mm outer spiral
sections and cutting to the desired size, providing unmatched
flexibility and precision in treatment.
Key Features of Shield Spiral:
- Graft Protection: Maintains the high standards of graft
protection as other products in the Kerecis Shield product
range.
- Porous Silicon Contact Layer: Ensures optimal
integration and healing.
- Customizable Design: A spiral pattern allows easy
tailoring to accommodate various wound sizes.
Shield Spiral is a part of the Kerecis Shield product family,
which consists of Shield Adhesive and Shield Standard. The products
are designed for managing chronic and acute wounds such as diabetic
foot ulcers, pressure ulcers, vascular ulcers, post-Moh's surgical
wounds, and draining wounds. The grafts contain essential natural
skin elements and are fenestrated to allow adequate wound drainage
for appropriate wound moisture at the wound bed.
"At Kerecis, we continue to be inspired by the insights of the
doctors that use the intact fish-skin every day," said Fertram
Sigurjonsson, Founder and CEO of Kerecis. “The development of
Shield Spiral is a direct result of feedback from doctors that
asked for a product that could be shaped faster and easier to the
size of smaller wounds.”
About Kerecis:
Kerecis was founded by Fertram Sigurjonsson to develop products
from fish skin and fatty acids for cellular therapy, tissue
regeneration and protection. When grafted onto damaged human tissue
or implanted, the patented material supports the body’s own
processes to heal and regenerate. Because no disease-transfer risk
exists between cold-water fish and humans, the Kerecis fish skin is
only gently processed and retains its similarity to human tissue.
The gentle processing preserves the skin’s original
three-dimensional structure, maintaining its inherent natural
strength, complexity and molecules (such as fatty acids). Clinical
studies have found that the Kerecis products heal wounds faster
than competing products. Kerecis is the only approved manufacturer
of medical devices containing intact fish skin globally.
Kerecis is the fastest-growing and one of the top five companies
in the U.S. biologics-skin and dermal-substitute market, according
to SmartTRAK Business Intelligence. Kerecis’ expanding product
portfolio includes SurgiBind®/SurgiClose®, which are used for
reconstructive surgery in hospital operating rooms; GraftGuide®,
which is mostly sold to burn centers; and MariGen® and Shield™,
which are sold to healthcare facilities to treat chronic wounds
such as diabetic wounds, as well as post-Moh's surgery wounds.
Kerecis is committed to the United Nations Sustainable
Development Goals. The fish skin used in Kerecis’ products derives
from wild and sustainable fish stock caught in pristine Icelandic
waters and processed with 100% renewable energy in the town of
Isafjordur, close to the Arctic Circle. Kerecis is part of
Coloplast, the leading global supplier of intimate healthcare
products. For more information, visit https://www.kerecis.com.
Trademarks and registered trademarks are the property of their
respective owners.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240705610282/en/
Hrannar Petursson Director of Communications & Digital
Engagement hpet@kerecis.com